Candidal Vulvovaginitis (Yeast Infection) Quiz
Check your symptoms and
find possible causes with AI for free
Worried about your symptoms?
Start the Candidal Vulvovaginitis (Yeast Infection) test with our free AI Symptom Checker.
This will help us personalize your assessment.
By starting the symptom checker, you agree to the Privacy Policy and Terms of Use
Vaginal itching
Change in vaginal discharge
White discharge
Vaginal pain
Vaginal irritation
Swollen vulva
Painful urination
Thick white discharge
Thick white discharge no smell
Foul smelling vaginal discharge
Sudden increase in vaginal discharge
Swollen vaginal glands
Not seeing your symptoms? No worries!
What is Candidal Vulvovaginitis (Yeast Infection)?
This is a fungal infection by Candida that affects the vaginal area. Candida normally exists on skin and vaginal linings without issues. An infection occurs when the skin or vaginal lining changes in character, promoting Candida overgrowth. People with weakened immune systems or on birth control pills may be at increased risk.
Typical Symptoms of Candidal Vulvovaginitis (Yeast Infection)
- Abnormal color, amount or odor of vaginal discharge
- Increase in vaginal discharge
- Itchiness around the vagina
- Increased vaginal discharge that is smelly
- Thick white vaginal discharge
- Pain or discomfort in the genital area
- Recent antibiotic use
- Mental stress and physical fatigue
Diagnostic Questions for Candidal Vulvovaginitis (Yeast Infection)
Your doctor may ask these questions to check for this disease:
- Have you noticed any changes in the color, amount, or odor of your vaginal discharge?
- Have you had more vaginal discharge lately?
- Are you experiencing itchiness around your vagina?
- Has the vaginal discharge odor worsened recently?
- Do you have a thick white discharge like cottage cheese or yogurt?
Treatment of Candidal Vulvovaginitis (Yeast Infection)
This is usually treated with antifungal drugs, which can be given through a vaginal cream or an oral antifungal medicine.
Reviewed By:
Scott Nass, MD, MPA, FAAFP, AAHIVS (Primary Care)
Dr. Nass received dual medical degrees from the David Geffen School of Medicine at UCLA and Charles R. Drew University in Medicine and Science. He completed Family Medicine residency at Ventura County Medical Center with subsequent fellowships at Ventura, University of North Carolina-Chapel Hill, George Washington University, and University of California-Irvine. He holds faculty appointments at Keck School of Medicine of USC, Loma Linda University School of Medicine, and Western University of Health Sciences.
Seiji Kanazawa, MD, PHD (Obstetrics and Gynecology (OBGYN))
Dr. Kanazawa graduated from the Niigata University Faculty of Medicine and received his Ph.D. from the Tohoku University Graduate School of Medicine. He is working on the front line of the General Perinatal Center, including the Tokyo Tama General Medical Center and the National Center for Research in Fertility Medicine, where he provides maternal and fetal care and undertakes clinical research. At Ubie, Dr. Kanazawa has been designing the Ubie AI Symptom Checker and has taken on the role of general obstetrics and gynecology consultation at FMC Tokyo Clinic by providing fetal ultrasound and prenatal consultation.
Content updated on Dec 13, 2024
Following the Medical Content Editorial Policy
Was this page helpful?
Tell your friends about us.
We would love to help them too.
Think you might have
Candidal Vulvovaginitis (Yeast Infection)?
Try a symptom check testHow Ubie Can Help You
With a free 3-min Candidal Vulvovaginitis (Yeast Infection) quiz, powered by Ubie's AI and doctors, find possible causes of your symptoms.
This questionnaire is customized to your situation and symptoms, including the following personal information:
Biological Sex - helps us provide relevant suggestions for male vs. female conditions.
Age - adjusts our guidance based on any age-related health factors.
History - considers past illnesses, surgeries, family history, and lifestyle choices.
Your symptoms
Our AI
Your report
Your personal report will tell you
✔ When to see a doctor
✔︎ What causes your symptoms
✔︎ Treatment information etc.
People with similar symptoms also use Ubie's symptom checker to find possible causes
- Vaginal discharge changed
- Lots of vaginal discharge
- Smelly vaginal discharge
- Genital itch
- White vaginal discharge
- Smelly vaginal discharge
- Increase in vaginal discharge
- Yellow vaginal discharge
- White vaginal discharge
- Greyish vaginal discharge
- Itchy vagina
- Increased vaginal discharge
- Slight increase in vaginal discharge
- My vagina smells
- Vaginal discharge odor
See full list
User Testimonials for Candidal Vulvovaginitis (Yeast Infection)
Female, 30s
The symptom checker helped me get a better idea of what was going on with me and eased my anxiety. Ubie even helped find me a doctor in my network, whom I'm consulting right away!
(Jun 16, 2025)
Symptoms Related to Candidal Vulvovaginitis (Yeast Infection)
Diseases Related to Candidal Vulvovaginitis (Yeast Infection)
FAQs
Q.
Yeast Infection Relief for Women 30-45: Your Essential Next Steps
A.
Essential next steps for women 30 to 45: confirm your symptoms really point to a yeast infection, treat with an appropriate OTC or prescribed antifungal, soothe with breathable cotton and cool compresses, avoid scented products, and see a clinician if symptoms are severe, last more than 7 to 10 days, or recur. There are several factors to consider, including conditions that mimic yeast infections and special situations like pregnancy, perimenopause, diabetes, and high estrogen birth control that change the safest treatment and prevention plan. See below to understand more, including prevention habits, red flags, and when longer therapy is needed.
References:
* Workowski, K. A., Bachmann, L. H., Chan, P. A., Johnston, C. M., Muzny, L., Reno, H., ... & Bolan, G. A. (2021). Sexually Transmitted Infections Treatment Guidelines, 2021. *MMWR. Recommendations and Reports*, *70*(4), 1-187. doi:10.15585/mmwr.rr7004a1.
* Marchaim, D., & Sobel, J. D. (2022). Vulvovaginal Candidiasis: Practical Clinical Considerations. *Infectious Disease Clinics of North America*, *36*(1), 173-189. doi:10.1016/j.idc.2021.10.007.
* Rosati, D., Bruno, M., Sepulveres, D., & Fegatilli, A. (2022). Vulvovaginal Candidiasis: Recurrence, Prevention, and Treatment. *Journal of Clinical Medicine*, *11*(16), 4697. doi:10.3390/jcm11164697.
* Sobel, J. D., & Nyirjesy, P. (2020). Recurrent vulvovaginal candidiasis. *Journal of women's health (2002)*, *29*(5), 707–714. doi:10.1089/jwh.2019.8222.
* Fidel, P. L., Jr. (2023). New insights into the pathogenesis and management of recurrent vulvovaginal candidiasis. *International Journal of Gynaecology and Obstetrics*, *160*(Suppl 1), 6-12. doi:10.1002/ijgo.14660.
Q.
Effective Yeast Infection Treatment After 65: Fast Relief & Prevention
A.
Fast, effective relief after 65 often uses OTC azole treatments like clotrimazole or miconazole in 7 day courses, with prescription options such as fluconazole or extended regimens for tougher or recurrent cases, but evaluation is key since symptoms can mimic other conditions. See below to understand more. To prevent recurrences, focus on moisture control, diabetes management, careful antibiotic use, and discussing vaginal estrogen when appropriate, and know when to see a doctor if symptoms persist, recur, or include pain, sores, bleeding, fever, or pelvic pain. There are several factors to consider, including drug interactions and safety screening, so see below for important details that can guide your next steps.
References:
* Donders GGG, Bellen G, De Sutter P. Vulvovaginal Candidiasis in Postmenopausal Women. Int J Gynaecol Obstet. 2017 Jan;136(1):15-18. doi: 10.1002/ijgo.12009. Epub 2016 Nov 1. PMID: 27726194.
* Sobel JD. Vulvovaginal Candidiasis: Epidemiology, Diagnosis, and Management. Am J Obstet Gynecol. 2021 Jan;224(1):1-10. doi: 10.1016/j.ajog.2020.07.018. Epub 2020 Aug 6. PMID: 32777322.
* Pappas PG, Sobel JD. Recurrent Vulvovaginal Candidiasis: An Update on Epidemiology, Pathogenesis, and Management. Sex Transm Dis. 2020 Sep;47(9):561-568. doi: 10.1097/OLQ.0000000000001217. PMID: 32796468.
* Marra V, Ghasemian R, Donders GGG. Topical and Oral Antifungal Agents for the Treatment of Vulvovaginal Candidiasis: A Review of Efficacy and Safety. Pharmaceuticals (Basel). 2023 Apr 15;16(4):597. doi: 10.3390/ph16040597. PMID: 37111005.
* Donders GGG, Ravel J, Bellen G, Van der Meersch E. Estrogen and Fungal Infection: A Complex Relationship. J Fungi (Basel). 2022 Nov 22;8(12):1224. doi: 10.3390/jof8121224. PMID: 36556100.
Q.
Vaginal Yeast Infection After 65: Causes, Relief & Prevention
A.
After 65, vaginal yeast infections are common and usually treatable; they are often driven by lower estrogen, medicines like antibiotics or steroids, diabetes or immune issues, and extra moisture from pads or briefs, and can cause itching, burning, dryness, or thick white discharge. Relief typically starts with confirming the diagnosis, then using antifungal creams or pills; if thinning and dryness contribute, low dose vaginal estrogen may help, and prevention includes breathable underwear, gentle unscented care, prompt changing when damp, and good blood sugar control. There are several factors to consider, including when to seek care for first-time or persistent symptoms, recurrent infections, or red flags like bleeding, severe pain, or fever; see the complete answer below for key details that can guide your next steps.
References:
* Patel, N., Langan, C. M., Ma, L., & Zevallos, C. (2023). Vulvovaginal candidiasis in postmenopausal women: A review of the literature. *Current Opinion in Obstetrics & Gynecology*, 35(1), 77-83.
* Costa, C., Ramalho, M., Neves, M., & Neves, A. (2022). Recurrent Vulvovaginal Candidiasis in Postmenopausal Women: A Systematic Review. *Journal of Clinical Medicine*, 11(24), 7368.
* Wu, M., Cheng, X., Zhang, W., & Li, S. (2020). Risk Factors for Recurrent Vulvovaginal Candidiasis in Postmenopausal Women: A Retrospective Study. *Journal of Lower Genital Tract Disease*, 24(1), 89-92.
* Singh, N. (2022). Genitourinary Syndrome of Menopause and Vulvovaginal Candidiasis: The Interplay. *Sexual Medicine Reviews*, 10(1), 15-20.
* Ogrich, L., & Schick, M. R. (2023). Vulvovaginal candidiasis: Updates on epidemiology, clinical manifestations, and management. *Current Fungal Infection Reports*, 17(4), 119-128.
Q.
Best Yeast Infection Treatments: A Woman's Clinical Guide
A.
The most effective yeast infection treatments are antifungal medications: over the counter clotrimazole or miconazole for mild cases, and prescription fluconazole for moderate to severe symptoms, with vaginal options preferred in pregnancy. There are several factors to consider, including confirming the diagnosis, when to see a clinician, how to manage recurrent infections, what home remedies to avoid, and prevention steps. See the complete guidance below to understand important details that could change your next steps.
References:
* Rosati D, Bruno M, Rubino B, Borgo F, Vecchione A. Vulvovaginal Candidiasis: Epidemiology, Pathogenesis, Diagnosis, and Management. Clin Microbiol Rev. 2020 Feb 26;33(2):e00086-19. doi: 10.1128/CMR.00086-19. PMID: 32102871; PMCID: PMC7048705.
* Denning DW, Colombo AL, Haglund M, Houbraken J, Melchers WJ, Nucci M, Rautemaa-Richardson R, Wiederhold N. Vulvovaginal candidiasis: a common, annoying, and sometimes complicated infection. BMC Womens Health. 2020 Apr 6;20(1):77. doi: 10.1186/s12905-020-00951-6. PMID: 32252758; PMCID: PMC7136367.
* Ilkit M. Clinical Management of Vulvovaginal Candidiasis. J Fungi (Basel). 2021 Jun 25;7(7):508. doi: 10.3390/jof7070508. PMID: 34208460; PMCID: PMC8308479.
* Sobel JD. Recurrent Vulvovaginal Candidiasis: An Update. Curr Fungal Infect Rep. 2021 Jun;15(2):100-106. doi: 10.1007/s12281-021-00392-1. Epub 2021 May 18. PMID: 34007137.
* Rylander A, Caddy S. Emerging therapeutics for vulvovaginal candidiasis. Expert Opin Emerg Drugs. 2022 Sep;27(3):361-370. doi: 10.1080/14728214.2022.2109867. Epub 2022 Aug 4. PMID: 35929624.
Q.
Safe Yeast Infection Relief for Seniors: Medical Options
A.
Safe relief for seniors includes OTC antifungal creams or suppositories like clotrimazole or miconazole, typically in 7-day courses, with prescription options such as fluconazole or stronger vaginal therapies for persistent or recurrent symptoms; proper diagnosis is crucial since look-alike conditions are common, and urgent care is warranted for fever, pelvic pain, bleeding, or worsening symptoms. There are several factors to consider, including drug interactions, kidney or liver issues, postmenopausal tissue changes that may benefit from low-dose vaginal estrogen, diabetes management, and care for skin or oral yeast. See below for complete guidance on when self-care is reasonable, how to manage recurrences, prevention tips, and what treatments and home remedies to avoid.
References:
* Li A, Zhou S, Chen D, Shen T. Candidiasis in Older Adults: A Narrative Review. *J Fungi (Basel)*. 2022 Aug 1;8(8):796. PMID: 35921609.
* Akpan A, Morgan R. Oral Candidiasis in the Elderly. *Postgrad Med J*. 2017 May;93(1099):296-302. PMID: 28575005.
* Denning DW, Kneale M, Sobel JD, Rautemaa-Richardson R. Recurrent vulvovaginal candidiasis in postmenopausal women: a review of the literature. *Mycoses*. 2019 Jul;62(7):599-606. PMID: 31336040.
* Patel V, Singh P, Madaan V, Madaan R. Antifungal Agents in the Geriatric Population: A Narrative Review. *J Fungi (Basel)*. 2021 Jul 20;7(7):577. PMID: 34299946.
* De Ryck R, Van Hecke S, Boussery K, Van der Kuyph D. Drug-drug interactions with azole antifungals: an update. *Expert Opin Drug Metab Toxicol*. 2021 Sep;17(9):1043-1055. PMID: 34190772.
Q.
Over 65 Starting Farxiga? What to Watch in the First 2 Weeks
A.
If you’re over 65 and beginning Farxiga, the first two weeks often bring more urination and thirst; watch for dizziness, low blood sugar if you also use insulin or a sulfonylurea, and early signs of genital yeast infections or UTIs. Seek urgent care for severe dehydration, reduced urination, fever or confusion, or possible ketoacidosis signs like nausea, belly pain, rapid breathing, or fruity breath; review diuretics, NSAIDs, blood pressure pills, insulin or sulfonylureas with your doctor, stay hydrated, monitor sugars, and pause and call your doctor if you develop vomiting or diarrhea. There are several factors to consider. See below for important details that can guide your next steps.
References:
* Tang W, Wu Y, Lu Y, Sun H, Huang M. Safety and tolerability of dapagliflozin in elderly patients with type 2 diabetes mellitus: a systematic review and meta-analysis. Aging Clin Exp Res. 2020 Feb;32(2):227-236. doi: 10.1007/s40520-019-01229-2. Epub 2019 May 14. PMID: 31087132.
https://pubmed.ncbi.nlm.nih.gov/31087132/
* Lertwattanarak R, Sripetchanda S, Wattanakitkrileart C, Ngamchuea K. Real-World Safety of Sodium-Glucose Cotransporter 2 Inhibitors in Elderly Patients With Type 2 Diabetes Mellitus: A Systematic Review. J Clin Med. 2023 Apr 1;12(7):2690. doi: 10.3390/jcm12072690. PMID: 37050013; PMCID: PMC10094916.
https://pubmed.ncbi.nlm.nih.gov/37050013/
* Zhang W, Xie H, Zhang G, Li Y. Early Adverse Events of SGLT2 Inhibitors and GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis. Front Pharmacol. 2021 Mar 1;12:646395. doi: 10.3389/fphar.2021.646395. PMID: 33737871; PMCID: PMC7960688.
https://pubmed.ncbi.nlm.nih.gov/33737871/
* Sun M, Zhao Z, Cui Z, Jia T. Risk of acute kidney injury with SGLT2 inhibitors: an updated systematic review and meta-analysis. Front Pharmacol. 2023 Feb 1;14:1062071. doi: 10.3389/fphar.2023.1062071. PMID: 36816049; PMCID: PMC9931346.
https://pubmed.ncbi.nlm.nih.gov/36816049/
* Palmer SC, Ruospo M, Palmer B, Strippoli GF, Jardine MJ, Navaneethan SD. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure and cardiorenal outcomes in older adults with type 2 diabetes: a systematic review and meta-analysis. Lancet Healthy Longev. 2022 Jan;3(1):e27-e39. doi: 10.1016/S2666-7568(21)00249-X. PMID: 36056976.
https://pubmed.ncbi.nlm.nih.gov/36056976/
Q.
The Real Reason Farxiga Can Make You Pee More (and When That’s Not Normal)
A.
Farxiga often makes you pee more because it blocks SGLT2 in the kidneys, so glucose is lost in the urine and water follows, a normal osmotic diuresis that is usually most noticeable early on and often comes with larger volumes and increased thirst. It is not normal if this comes with dehydration signs, burning or urgency, genital itching or discharge, waking many times at night, or serious symptoms like nausea, vomiting, shortness of breath, confusion, or extreme fatigue, in which case you should seek care. There are several factors to consider and practical steps that can change your next best move, so see the complete answer below.
References:
* Scheen AJ. SGLT2 inhibitors: mechanisms of action and effects on the kidney. Curr Opin Nephrol Hypertens. 2018 May;27(3):195-201. doi: 10.1097/MNH.0000000000000407. PMID: 29555437.
* Wilding JP, Cannon CP, Perkovic V, et al. SGLT2 inhibitors: clinical perspectives. Lancet Diabetes Endocrinol. 2019 Jul;7(7):545-562. doi: 10.1016/S2213-8587(19)30154-0. PMID: 31032333.
* Anjana Y, Unnikrishnan R, Madhu SV. Sodium-glucose cotransporter 2 inhibitors (SGLT2i) in cardiovascular, renal, and metabolic diseases: A review of clinical trials. Indian J Endocrinol Metab. 2021 Nov-Dec;25(6):448-456. doi: 10.4103/ijem.ijem_473_21. PMID: 35055577.
* Lillo SM, Lillo AM, Al-Khalidi S. Adverse effects of SGLT2 inhibitors and their management. Curr Opin Endocrinol Diabetes Obes. 2021 Apr;28(2):167-172. doi: 10.1097/MED.0000000000000624. PMID: 33431666.
* Deeks ED. Dapagliflozin: A Review in Type 2 Diabetes. Drugs. 2015 May;75(7):777-802. doi: 10.1007/s40265-015-0391-y. PMID: 25776269.
Q.
What Is Farxiga? How It Works, What It Treats, and Key Safety Warnings
A.
Farxiga (dapagliflozin) is an SGLT2 inhibitor taken once daily that lowers blood sugar by helping the kidneys excrete glucose and is also proven to reduce heart failure hospitalizations and slow chronic kidney disease progression, including in some people without diabetes. Key safety points include risks of dehydration and low blood pressure, rare ketoacidosis, urinary and genital infections, and kidney function changes, and it is not for type 1 diabetes or treating DKA. There are several factors and exceptions that could affect your next steps; see the complete indications, dosing, and safety guidance below.
References:
Kosiborod MN, et al. Dapagliflozin: A Review in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease. Drugs. 2021 Jan;81(1):153-166. doi: 10.1007/s40265-020-01449-7. PMID: 33400262.
https://pubmed.ncbi.nlm.nih.gov/33400262/
Krum S, et al. Safety of Dapagliflozin: A Comprehensive Review of Clinical Trials and Post-Marketing Data. Curr Med Res Opin. 2020 Jul;36(7):1103-1113. doi: 10.1080/03007995.2020.1758953. PMID: 32308197.
https://pubmed.ncbi.nlm.nih.gov/32308197/
McMurray JJV, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. PMID: 31535829.
https://pubmed.ncbi.nlm.nih.gov/31535829/
Wiviott SD, et al. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2019 Jan 24;380(9):831-841. doi: 10.1056/NEJMoa1812301. PMID: 30426816.
https://pubmed.ncbi.nlm.nih.gov/30426816/
Heerspink HJL, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2020 Oct 8;383(23):2219-2229. doi: 10.1056/NEJMoa2024816. PMID: 32970396.
Q.
How to get rid of a yeast infection in 24 hours?
A.
Rapid symptom relief within about 24 hours is realistic: take a single 150 mg fluconazole tablet or use an OTC intravaginal azole such as tioconazole or miconazole, and complete the recommended course even if you feel better. There are several factors to consider, including pregnancy and medication interactions, correct application, supportive steps like breathable underwear and no douching, and when to follow up if symptoms persist 48 to 72 hours; see the full guidance below.
References:
Pappas PG, Kauffman CA, Andes DR, et al. (2016). Clinical practice guideline for the management of vulvovaginal candidiasis: 2016 update by the Infectious… Clin Infect Dis, 27418564.
Workowski KA, Bolan GA. (2015). Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep, 26068404.
Sobel JD, Rinaldi MG, Fazili T. (1999). Comparative evaluation of single‐dose oral fluconazole and topical imidazole therapy for acute vulvovaginal… Obstet Gynecol, 10305253.
Q.
How to treat yeast infection?
A.
Most uncomplicated yeast infections can be treated with over-the-counter azole antifungal creams or suppositories; if symptoms do not improve within a few days or recur, a clinician may prescribe oral fluconazole or alternatives like boric acid or nystatin. There are several factors to consider, including pregnancy, recurrent infections, diabetes or immunocompromise, and red flags like severe pain or fever; complete your treatment course and see the detailed guidance below for safe options, dosing, prevention tips, and when to seek urgent care.
References:
Zhang S, Liu P, Li C, Wu Y, & Zhang T. (2018). Treatment of uncomplicated vulvovaginal candidiasis: a system… BMC Infectious Diseases, 30358305.
Infectious Diseases Society of America. (2016). Clinical practice guideline for the management of candidiasis… Clinical Infectious Diseases, 26679614.
Sobel JD. (2007). Vulvovaginal candidiasis. Lancet, 17400038.
Q.
What causes yeast infection?
A.
Yeast infections occur when Candida albicans, a fungus that normally lives in the vagina, overgrows due to disruptions such as recent antibiotics that lower protective Lactobacillus and raise pH, higher estrogen levels, poorly controlled diabetes, weakened immunity, trapped heat and moisture, douching or scented products, high-sugar diets, and stress. There are several factors to consider; see below for key details that may change your next steps, including specific risk situations, prevention tips, typical symptoms, and when to seek medical care.
References:
Sobel JD. (2007). Vulvovaginal candidosis: pathogenesis, epidemiology, and… Lancet Infect Dis, 17448953.
Odds FC, Brown AJ, & Gow NA. (2003). Morphogenesis in Candida albicans: progress… Trends Microbiol, 12892967.
Richardson MD, & Lass-Flörl C. (2008). Changing epidemiology of systemic fungal infections. Clin Microbiol Infect, 18783023.
Ubie is supervised by 50+ medical experts worldwide
Our symptom checker AI is continuously refined with input from experienced physicians, empowering them to make more accurate diagnoses.
Ubie is recognized by healthcare and tech leaders
“World’s Best Digital
Health Companies”
Newsweek 2024
“Best With AI”
Google Play Best of 2023
“Best in Class”
Digital Health Awards 2023 (Quarterfinalist)
Which is the best Symptom Checker?
Ubie’s symptom checker demonstrated a Top-10 hit accuracy of 71.6%, surpassing the performance of several leading symptom checkers in the market, which averaged around 60% accuracy in similar assessments.
Link to full study:
https://www.medrxiv.org/content/10.1101/2024.08.29.24312810v1References
Donders GG, Sobel JD. Candida vulvovaginitis: A store with a buttery and a show window. Mycoses. 2017 Feb;60(2):70-72. doi: 10.1111/myc.12572. Epub 2016 Sep 30. PMID: 27687503.
https://onlinelibrary.wiley.com/doi/10.1111/myc.12572Sobel JD. Candida vulvovaginitis. Semin Dermatol. 1996 Mar;15(1):17-28. doi: 10.1016/s1085-5629(96)80014-9. PMID: 8723820.
https://linkinghub.elsevier.com/retrieve/pii/S1085562996800149